Stroke Journal

FEBRUARY 1, 2024

The 21-point Brain Care Score (BCS) is a novel tool designed to motivate individuals and care providers to take action to reduce the risk of stroke and dementia by motivating lifestyle changes (Fig 1). FA/MD metrics were calculated as the average across 48 discrete brain regions.

Dementia 40

Dementia Risk Factors Stroke Strokes 40

Dr. Paddy Barrett

AUGUST 22, 2023

Being a carrier of the APOE4 gene variant is associated with higher rates of the most common type of dementia, late-onset dementia. Of those with late-onset dementia, up to 65% are carriers of the APOE4 gene variant 1. Of those with late-onset dementia, up to 65% are carriers of the APOE4 gene variant 1. What to do?

Cholesterol 52

Cholesterol Dementia Coronary Artery Disease Cardiovascular Disease 52

Stroke Journal

DECEMBER 5, 2024

We aimed to investigate whether socioeconomic status was associated with the rate of poststroke dementia (PSD).METHODS:This METHODS:This was a nationwide register-based cohort study including all patients with incident ischemic or hemorrhagic stroke in Denmark from 2010 to 2020. Median age was 72 (6280) years, 56% were male, 5.1%

Dementia 40

Dementia Education Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Cancer is an emerging risk factor for ischemic stroke. Stroke, Volume 55, Issue Suppl_1 , Page ATMP105-ATMP105, February 1, 2024. Patients were randomly selected for model derivation (60%) or validation (40%). The overall rate of stroke per 1000 person-years was 6.7 (6.4 6.4 - 6.9) for the derivation cohort.

Cancer 40

Cancer Stroke Strokes Atrial Fibrillation 40

Dr. Smith's ECG Blog

APRIL 8, 2015

Until then, I consider any of these to be independent adverse risk factors. -- Finally, a dedicated syncope unit may improve evaluation and outcome (17). . -- Finally, a dedicated syncope unit may improve evaluation and outcome (17). The ROSE (Risk Stratification of syncope in the emergency department) Study.

Arrhythmia 52

Arrhythmia Outcomes Chest Pain Risk Factors 52

Dr. Malcolm Kendrick

OCTOBER 30, 2024

Assessing the potential for SenseCam to fight the current global health crises of increasing obesity and physical inactivity (2010-2013) Microsoft: £69K ATLAS trial of tamoxifen duration (1997-2018) AstraZeneca: £1.0M Elinogrel feasibility trial (2010-2011) Novartis: £500K EMPA-KIDNEY (2017-ongoing) Boehringer Ingelheim: £106.3M

Cholesterol 145

Cholesterol Article Research Diet 145